Radiation Therapy Oncology Group 0521: A phase III randomized trial of androgen suppression and radiation therapy versus androgen suppression and radiation therapy followed by chemotherapy with docetaxel/prednisone for localized, high-risk prostate cancer

Asmita R. Patel, Howard M. Sandler, Kenneth Pienta

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)212-214
Number of pages3
JournalClinical Genitourinary Cancer
Volume4
Issue number3
DOIs
StatePublished - Dec 2005
Externally publishedYes

Fingerprint

Phytogenic Antineoplastic Agents
docetaxel
Androgen Antagonists
Taxoids
Combined Modality Therapy
Radiation Oncology
Neoplasm Staging
Survival Analysis
Prednisone
Androgens
Prostatic Neoplasms
Adrenal Cortex Hormones
Radiotherapy
Drug Therapy

Keywords

  • Hormone-naive disease
  • Intensity-modulated radiation therapy
  • Locally advanced disease

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

@article{d766f9f498024ee9bf2817ad9928e5ef,
title = "Radiation Therapy Oncology Group 0521: A phase III randomized trial of androgen suppression and radiation therapy versus androgen suppression and radiation therapy followed by chemotherapy with docetaxel/prednisone for localized, high-risk prostate cancer",
keywords = "Hormone-naive disease, Intensity-modulated radiation therapy, Locally advanced disease",
author = "Patel, {Asmita R.} and Sandler, {Howard M.} and Kenneth Pienta",
year = "2005",
month = "12",
doi = "10.3816/CGC.2005.n.035",
language = "English (US)",
volume = "4",
pages = "212--214",
journal = "Clinical Genitourinary Cancer",
issn = "1558-7673",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Radiation Therapy Oncology Group 0521

T2 - A phase III randomized trial of androgen suppression and radiation therapy versus androgen suppression and radiation therapy followed by chemotherapy with docetaxel/prednisone for localized, high-risk prostate cancer

AU - Patel, Asmita R.

AU - Sandler, Howard M.

AU - Pienta, Kenneth

PY - 2005/12

Y1 - 2005/12

KW - Hormone-naive disease

KW - Intensity-modulated radiation therapy

KW - Locally advanced disease

UR - http://www.scopus.com/inward/record.url?scp=33644961408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644961408&partnerID=8YFLogxK

U2 - 10.3816/CGC.2005.n.035

DO - 10.3816/CGC.2005.n.035

M3 - Article

C2 - 16425991

AN - SCOPUS:33644961408

VL - 4

SP - 212

EP - 214

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

SN - 1558-7673

IS - 3

ER -